Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | p-Xylyl bromide | HCID 7721 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 67354960 | HCID 67354960 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 53361086 | HCID 53361086 | 85.3% |
Reaction Steps
To a DMF (5 mL) solution of (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}-1-(4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (479 mg) and 4-methylbenzyl bromide (155 mg) was added sodium hydride (60% w/w in oil, 42 mg) at 0° C., and stirred for 1 hour. The reaction mixture was quenched by addition of saturated aqueous NH4Cl (10 mL), and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (AcOEt/MeOH=1/0 to 9/1) to afford (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-(4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (480 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08722663B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-ff20e95d134441d694731fc38d092e44 |
|---|
| Source note | uspto-grants-2014_05 |
|---|